NeuBase Therapeutics, Inc.: Nasdaq/NYSE listing notice — NeuBase receives Nasdaq notice of additional 180-day compliance period for bid price deficiency

NeuBase Therapeutics, Inc.

Nasdaq granted NeuBase until September 25, 2023 to regain minimum bid price of $1.00 per share.
Company failed to meet minimum bid price requirement by initial deadline of March 28, 2023.
Company intends to consider options including reverse stock split to regain compliance.
If not compliant by September 25, 2023, Nasdaq will delist; company may appeal.
Stock continues trading on Nasdaq Capital Market during additional period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

NeuBase Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 29, 2023, Nasdaq notified the Company in writing that while the Company had not regained compliance with the Minimum Bid Price Requirement, it was eligible for an additional 180 calendar day period, or until September 25, 2023, to regain compliance with the Minimum Bid Price Requirement. Nasdaq’s determination was based on the Company having met the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on the Company’s writt

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-038395

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.